BioWorld - Sunday, November 23, 2025 See today's BioWorld MedTech Home » Billiontoone’s Unity screen IDs cystic fibrosis, enables in utero treatment To read the full story, subscribe or sign in.
MENLO PARK, Calif., Dec. 6, 2022 /PRNewswire/ -- New clinical outcomes data [1] show the ability of UNITY Screen™ to accurately identify pregnancies at risk for recessively inherited genetic ...
MENLO PARK, Calif., Sept. 30, 2022 /PRNewswire/ -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback